tetrabenazine

Generic: tetrabenazine

Labeler: slate run pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tetrabenazine
Generic Name tetrabenazine
Labeler slate run pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tetrabenazine 12.5 mg/1

Manufacturer
Slate Run Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 70436-101
Product ID 70436-101_de4c0693-1b76-4026-bd94-a7a5dcc8a376
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213316
Listing Expiration 2026-12-31
Marketing Start 2020-03-02

Pharmacologic Class

Established (EPC)
vesicular monoamine transporter 2 inhibitor [epc]
Mechanism of Action
vesicular monoamine transporter 2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436101
Hyphenated Format 70436-101

Supplemental Identifiers

RxCUI
199592 805464
UPC
0370436102099 0370436101092
UNII
Z9O08YRN8O
NUI
N0000190856 N0000190855

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tetrabenazine (source: ndc)
Generic Name tetrabenazine (source: ndc)
Application Number ANDA213316 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
source: ndc
Packaging
  • 112 TABLET in 1 BOTTLE (70436-101-09)
source: ndc

Packages (1)

70436-101-09 112 TABLET in 1 BOTTLE (70436-101-09)

Ingredients (1)

tetrabenazine (12.5 mg/1)

Linked Drug Pages (1)

tetrabenazine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "de4c0693-1b76-4026-bd94-a7a5dcc8a376", "openfda": {"nui": ["N0000190856", "N0000190855"], "upc": ["0370436102099", "0370436101092"], "unii": ["Z9O08YRN8O"], "rxcui": ["199592", "805464"], "spl_set_id": ["49587379-1cc0-48ff-9f2f-517079cf499d"], "pharm_class_epc": ["Vesicular Monoamine Transporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Vesicular Monoamine Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "112 TABLET in 1 BOTTLE (70436-101-09)", "package_ndc": "70436-101-09", "marketing_start_date": "20200302"}], "brand_name": "tetrabenazine", "product_id": "70436-101_de4c0693-1b76-4026-bd94-a7a5dcc8a376", "dosage_form": "TABLET", "pharm_class": ["Vesicular Monoamine Transporter 2 Inhibitor [EPC]", "Vesicular Monoamine Transporter 2 Inhibitors [MoA]"], "product_ndc": "70436-101", "generic_name": "tetrabenazine", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tetrabenazine", "active_ingredients": [{"name": "TETRABENAZINE", "strength": "12.5 mg/1"}], "application_number": "ANDA213316", "marketing_category": "ANDA", "marketing_start_date": "20200302", "listing_expiration_date": "20261231"}